Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
NCT06034327
This study is recruiting at 14 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy. This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel group study.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Myopia
- Juvenile Myopia
- Myopia Progression
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 6 to 8 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- SightGlass Vision, Inc.
- Last updated on ClinicalTrials.gov
- December 29, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 4
- Elsa Pao, OD · Oakland, CA
- Scripps Poway Eyecare · San Diego, CA
- Pacific Rims Optometry · San Francisco, CA
- Paje Optometric · Santa Ana, CA
Florida · 1
- Omega Vision Center · Longwood, FL
Georgia · 1
- Marietta Eye Clinic · Marietta, GA
Illinois · 1
- Ilinois College of Optometry · Chicago, IL
Kansas · 1
- Kannarr Eye Care · Pittsburg, KS
Massachusetts · 1
- New England College of Optometry · Boston, MA
Missouri · 1
- Advanced Eyecare PC · Raytown, MO
Ohio · 2
- Athens Eye Care · Athens, OH
- Procare Vision Centers, Inc. · Granville, OH
Texas · 2
- Texas State Optical - Dowlen · Beaumont, TX
- Bellaire Family Eye Care · Bellaire, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.